Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11857340rdf:typepubmed:Citationlld:pubmed
pubmed-article:11857340lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:11857340lifeskim:mentionsumls-concept:C0019774lld:lifeskim
pubmed-article:11857340lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:11857340lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:11857340lifeskim:mentionsumls-concept:C0205360lld:lifeskim
pubmed-article:11857340pubmed:issue3lld:pubmed
pubmed-article:11857340pubmed:dateCreated2002-3-7lld:pubmed
pubmed-article:11857340pubmed:abstractTextImmunodominant T cell epitopes from the autoantigen human cartilage glycoprotein 39 have previously been mapped in the context of HLA-DR*0401 and *0402, using mice expressing HLA-DR4 transgenes. We measured the dissociation rates of these epitopes from soluble recombinant DR*0401 and DR*0402 to assess the relationship between peptide/HLA-DR4 kinetic stability and immunogenicity. Experiments were performed at endosomal pH (5.5) and at cell surface pH (7), in the absence and presence of soluble recombinant HLA-DM (sDM). All (4/4) immunodominant peptide/HLA-DR complexes exhibit dissociation half-times of 1h to several days. In contrast, most (3/4) non-immunodominant complexes dissociate with half-times <30 min under at least one of these conditions. Interestingly, a complex which is stable except in the presence of HLA-DM at pH 5.5 is immunogenic only following peptide immunization, while a complex which is stable at acidic but not at neutral pH, is non-immunogenic following either whole protein or peptide immunization. These data indicate that kinetic stability of peptide/MHC complexes in vivo is a key determinant of immunogenicity.lld:pubmed
pubmed-article:11857340pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:languageenglld:pubmed
pubmed-article:11857340pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:citationSubsetIMlld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11857340pubmed:statusMEDLINElld:pubmed
pubmed-article:11857340pubmed:monthMarlld:pubmed
pubmed-article:11857340pubmed:issn0014-2980lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:HallFrances...lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:RabinowitzJos...lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:BuschRobertRlld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:ViscontiKevin...lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:BelmaresMicha...lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:PatilNamrata...lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:CopeAndrew...lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:PatelSalilSlld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:McConnellHard...lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:MellinsElizab...lld:pubmed
pubmed-article:11857340pubmed:authorpubmed-author:SonderstrupGr...lld:pubmed
pubmed-article:11857340pubmed:issnTypePrintlld:pubmed
pubmed-article:11857340pubmed:volume32lld:pubmed
pubmed-article:11857340pubmed:ownerNLMlld:pubmed
pubmed-article:11857340pubmed:authorsCompleteYlld:pubmed
pubmed-article:11857340pubmed:pagination662-70lld:pubmed
pubmed-article:11857340pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:meshHeadingpubmed-meshheading:11857340...lld:pubmed
pubmed-article:11857340pubmed:year2002lld:pubmed
pubmed-article:11857340pubmed:articleTitleRelationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.lld:pubmed
pubmed-article:11857340pubmed:affiliationDepartment of Microbiology and Immunology, Stanford University, Stanford, CA 94305, USA.lld:pubmed
pubmed-article:11857340pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11857340pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11857340pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11857340pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11857340lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11857340lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11857340lld:pubmed